metformin has been researched along with Hypoalbuminemia in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Hypoalbuminemia: A condition in which albumin level in blood (SERUM ALBUMIN) is below the normal range. Hypoalbuminemia may be due to decreased hepatic albumin synthesis, increased albumin catabolism, altered albumin distribution, or albumin loss through the urine (ALBUMINURIA).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Steyn, M | 1 |
| Couchman, L | 1 |
| Coombes, G | 1 |
| Earle, KA | 1 |
| Johnston, A | 1 |
| Holt, DW | 1 |
1 other study available for metformin and Hypoalbuminemia
| Article | Year |
|---|---|
A herbal treatment for type 2 diabetes adulterated with undisclosed drugs.
Topics: Diabetes Mellitus, Type 2; Drug Contamination; Female; Glyburide; Humans; Hypoalbuminemia; Hypoglyce | 2018 |